N. Haertel

Multiparametric phenotyping of compound effects on patient derived organoids

M. Ebert, M. Boutros, Bernd Fischer, 2019 .

A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

M. Ebert, Nadja M Meindl-Beinker, T. Zhan, 2019, BMC Cancer.

Frailty predicts outcome of partial nephrectomy and guides treatment decision towards active surveillance and tumor ablation

M. Walach, M. Kriegmair, N. Rathmann, 2021, World Journal of Urology.

Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells.

H. Schild, M. Fountoulakis, D. Leppert, 2006, European journal of pharmacology.

Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment

O. Golubnitschaja, D. Trog, N. Haertel, 2005, Amino Acids.

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.

Jakob Nikolas Kather, M. Ebert, R. Hofheinz, 2022, The Lancet. Healthy longevity.

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

M. Ebert, R. Jesenofsky, E. Burgermeister, 2018, BMC Cancer.

Nab-paclitaxel/gemcitabine first-line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin levels: Data from the German QoliXane Pancreatic Cancer Registry.

M. Stauch, R. Hofheinz, J. Roemmler-Zehrer, 2016 .